These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 17701579)

  • 41. Outpatient reduced-intensity allogeneic stem cell transplantation for patients with refractory or relapsed lymphomas compared with autologous stem cell transplantation using a simplified method.
    Gutiérrez-Aguirre CH; Ruiz-Argüelles G; Cantú-Rodríguez OG; González-Llano O; Jaime-Pérez JC; García-Rodríguez F; López-Otero A; Herrera-Garza JL; Gómez-Almaguer D
    Ann Hematol; 2010 Oct; 89(10):1045-52. PubMed ID: 20490794
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The role of high-dose therapy and stem cell rescue in the management of T-cell malignant lymphomas: a BSBMT and ABMTRR study.
    Feyler S; Prince HM; Pearce R; Towlson K; Nivison-Smith I; Schey S; Gibson J; Patton N; Bradstock K; Marks DI; Cook G
    Bone Marrow Transplant; 2007 Sep; 40(5):443-50. PubMed ID: 17589529
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment approaches in relapsed or refractory peripheral T-cell lymphomas.
    Foster C; Kuruvilla J
    F1000Res; 2020; 9():. PubMed ID: 32934797
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Efficacy of High-Dose Therapy and Autologous Hematopoietic Cell Transplantation in Peripheral T Cell Lymphomas as Front-Line Consolidation or in the Relapsed/Refractory Setting: A Systematic Review/Meta-Analysis.
    El-Asmar J; Reljic T; Ayala E; Hamadani M; Nishihori T; Kumar A; Kharfan-Dabaja MA
    Biol Blood Marrow Transplant; 2016 May; 22(5):802-14. PubMed ID: 26713431
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Autologous stem-cell transplantation as first-line therapy in peripheral T-cell lymphomas: results of a prospective multicenter study.
    Reimer P; Rüdiger T; Geissinger E; Weissinger F; Nerl C; Schmitz N; Engert A; Einsele H; Müller-Hermelink HK; Wilhelm M
    J Clin Oncol; 2009 Jan; 27(1):106-13. PubMed ID: 19029417
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Peripheral T-cell lymphoma--not otherwise specified.
    Savage KJ; Ferreri AJ; Zinzani PL; Pileri SA
    Crit Rev Oncol Hematol; 2011 Sep; 79(3):321-9. PubMed ID: 20702104
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Controversies in lymphoma: the role of hematopoietic cell transplantation for mantle cell lymphoma and peripheral T cell lymphoma.
    Dreger P; Laport GG
    Biol Blood Marrow Transplant; 2008 Jan; 14(1 Suppl 1):100-7. PubMed ID: 18162229
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The diagnosis, management, and role of hematopoietic stem cell transplantation in aggressive peripheral T-cell neoplasms.
    Rezania D; Cualing HD; Ayala E
    Cancer Control; 2007 Apr; 14(2):151-9. PubMed ID: 17387300
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The role of autologous stem cell transplantation in peripheral T cell lymphoma: a long-term follow-up single-center experience.
    Roerden M; Walz JS; Müller MR; Sökler M; Federmann B; Kanz L; Bethge W; Vogel W
    J Cancer Res Clin Oncol; 2019 Oct; 145(10):2595-2604. PubMed ID: 31410605
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Non-anaplastic peripheral T cell lymphoma in children and adolescents-an international review of 143 cases.
    Mellgren K; Attarbaschi A; Abla O; Alexander S; Bomken S; Bubanska E; Chiang A; Csóka M; Fedorova A; Kabickova E; Kapuscinska-Kemblowska L; Kobayashi R; Krenova Z; Meyer-Wentrup F; Miakova N; Pillon M; Plat G; Uyttebroeck A; Williams D; Wróbel G; Kontny U;
    Ann Hematol; 2016 Aug; 95(8):1295-305. PubMed ID: 27270301
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Current state of art for transplantation paradigms in peripheral T-cell lymphomas.
    Perrone G; Farina L; Corradini P
    Expert Rev Hematol; 2013 Aug; 6(4):465-74. PubMed ID: 23991932
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Allogeneic transplantation in T-cell lymphomas.
    Schmitz N; Wu HS; Glass B
    Semin Hematol; 2014 Jan; 51(1):67-72. PubMed ID: 24468318
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ten-year follow-up of pediatric patients with non-Hodgkin lymphoma treated with allogeneic or autologous stem cell transplantation.
    Giulino-Roth L; Ricafort R; Kernan NA; Small TN; Trippett TM; Steinherz PG; Prockop SE; Scaradavou A; Chiu M; O'Reilly RJ; Boulad F
    Pediatr Blood Cancer; 2013 Dec; 60(12):2018-24. PubMed ID: 24038967
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Use of brentuximab vedotin as salvage therapy pre-allogeneic stem cell transplantation in relapsed/refractory CD30 positive lympho-proliferative disorders: a single centre experience.
    Mediwake H; Morris K; Curley C; Butler J; Kennedy G
    Intern Med J; 2017 May; 47(5):574-578. PubMed ID: 28247950
    [TBL] [Abstract][Full Text] [Related]  

  • 55. NCCN Guidelines Insights: Non-Hodgkin's Lymphomas, Version 3.2016.
    Horwitz SM; Zelenetz AD; Gordon LI; Wierda WG; Abramson JS; Advani RH; Andreadis CB; Bartlett N; Byrd JC; Fayad LE; Fisher RI; Glenn MJ; Habermann TM; Lee Harris N; Hernandez-Ilizaliturri F; Hoppe RT; Kaminski MS; Kelsey CR; Kim YH; Krivacic S; LaCasce AS; Lunning M; Nademanee A; Press O; Rabinovitch R; Reddy N; Reid E; Roberts K; Saad AA; Sokol L; Swinnen LJ; Vose JM; Yahalom J; Zafar N; Dwyer M; Sundar H; Porcu P
    J Natl Compr Canc Netw; 2016 Sep; 14(9):1067-79. PubMed ID: 27587620
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Primary treatment response rather than front line stem cell transplantation is crucial for long term outcome of peripheral T-cell lymphomas.
    Gritti G; Boschini C; Rossi A; Delaini F; Grassi A; Algarotti A; Micò C; Trezzi R; Gianatti A; Barbui AM; Rambaldi A
    PLoS One; 2015; 10(3):e0121822. PubMed ID: 25815886
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Autologous transplantation for relapsed or primary refractory peripheral T-cell lymphoma.
    Kewalramani T; Zelenetz AD; Teruya-Feldstein J; Hamlin P; Yahalom J; Horwitz S; Nimer SD; Moskowitz CH
    Br J Haematol; 2006 Jul; 134(2):202-7. PubMed ID: 16759221
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Stem cell transplantation as a biological therapy for peripheral T-cell lymphomas.
    Abouyabis AN; Shenoy PJ; Lechowicz MJ; Flowers CR
    Expert Opin Biol Ther; 2011 Jan; 11(1):31-40. PubMed ID: 21073355
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Current treatment of peripheral T-cell lymphoma.
    Horwitz SM; Coiffier B; Hsi ED; Pro B
    Clin Adv Hematol Oncol; 2011 Aug; 9(8 Suppl 16):1-15. PubMed ID: 22361915
    [TBL] [Abstract][Full Text] [Related]  

  • 60. High-dose chemotherapy and autologous stem cell transplantation for peripheral T-cell lymphoma: complete response at transplant predicts survival.
    Kim MK; Kim S; Lee SS; Sym SJ; Lee DH; Jang S; Park CJ; Chi HS; Huh J; Suh C
    Ann Hematol; 2007 Jun; 86(6):435-42. PubMed ID: 17256144
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.